Real-World Switch Rates, Treatment Patterns, and Healthcare Costs Among Patients With Spasticity Treated With Botulinum Toxins. [PDF]
Adv TherDominguez A +3 more
europepmc +1 more source
Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins. [PDF]
Mov Disord Clin PractMinacapilli E +4 more
europepmc +1 more source
New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators. [PDF]
Int J Mol Sci, 2019 Tang M, Meng J, Wang J.
europepmc +1 more source
SERS-Based Immunoassays for the Detection of Botulinum Toxins A and B Using Magnetic Beads. [PDF]
Sensors (Basel), 2019 Kim K, Choi N, Jeon JH, Rhie GE, Choo J.
europepmc +1 more source
The Esthetic Use of Botulinum Toxins in Cancer Patients: Providing a Foundation for Future Indications. [PDF]
Toxins (Basel)Papagni M +4 more
europepmc +1 more source
Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm. [PDF]
Toxins (Basel)Hast MA +5 more
europepmc +1 more source
Botulinum toxins in clinical practice: Gaps in knowledge. [PDF]
Neurol Clin Pract, 2016 Barbano RL.
europepmc +1 more source
Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity. [PDF]
Toxins (Basel), 2018 Fonfria E +4 more
europepmc +1 more source
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial. [PDF]
PM R, 2020 Esquenazi A +10 more
europepmc +1 more source